A newly published study in Mucosal Immunology shows that cannabidiol (CBD) – the non-psychoactive compound found in cannabis – may prevent mucosal HIV-1 transmission by directly targeting key immune cells involved in early viral spread.
CBD Inhibits HIV Infection in Multiple Cell Types
The research, based on ex vivo experiments using human tissue, demonstrates that CBD can inhibit HIV-1 infection in macrophages and CD4 T cells, which are the primary targets the virus uses to establish infection.
The study also found that CBD blocks virus transfer mediated by Langerhans cells and dendritic cells to CD4 T cells. This step is considered critical in mucosal HIV transmission, as these immune cells capture the virus and pass it on to susceptible T cells.
Mechanistically, the effect appears to involve activation of TRPV1 ion channels, leading to increased release of CGRP (calcitonin gene-related peptide), a neuropeptide shown to suppress viral transfer between cells.
Get the week’s important news from Cannabis.se in your inbox — interesting weekend reading! 🥦✉️
Blocking Early Transmission Events
Researchers further observed that CBD interferes with early events in HIV-1 transmission in human skin and mucosal tissues. Specifically, CBD reduced the formation of cellular contacts between Langerhans cells and CD4 T cells, which are normally required for efficient viral spread.
By disrupting these early cellular interactions, CBD may significantly limit the virus’s ability to establish infection at mucosal entry sites.
A Potential New Role for CBD in HIV Prevention
The findings suggest that CBD could potentially be developed as a prophylactic tool against HIV-1 infection, possibly as a complementary strategy alongside established pre-exposure prophylaxis (PrEP) treatments.
While the results are based on laboratory models and further clinical research is required, the study highlights a previously underexplored immunomodulatory effect of CBD with potential relevance for HIV prevention strategies.
Sponsor: Sensi Seeds are one of Europe’s most recognized names in premium cannabis genetics, offering a wide selection of feminized, autoflowering, CBD-rich and F1 hybrid seeds for customers who want quality, consistency and choice.